Proficio Capital Partners LLC purchased a new stake in Synopsys, Inc. (NASDAQ:SNPS – Free Report) during the second quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund purchased 1,627 shares of the semiconductor company’s stock, valued at approximately $726,000.
Other large investors also recently made changes to their positions in the company. Rehmann Capital Advisory Group boosted its stake in Synopsys by 7.0% in the 2nd quarter. Rehmann Capital Advisory Group now owns 1,841 shares of the semiconductor company’s stock worth $831,000 after purchasing an additional 120 shares during the period. Covington Investment Advisors Inc. raised its stake in shares of Synopsys by 15.0% in the 2nd quarter. Covington Investment Advisors Inc. now owns 20,602 shares of the semiconductor company’s stock valued at $9,190,000 after purchasing an additional 2,688 shares during the period. CTC Alternative Strategies Ltd. acquired a new stake in shares of Synopsys in the 2nd quarter valued at about $500,000. Headlands Technologies LLC lifted its holdings in shares of Synopsys by 144.0% in the second quarter. Headlands Technologies LLC now owns 6,516 shares of the semiconductor company’s stock valued at $2,907,000 after purchasing an additional 3,846 shares in the last quarter. Finally, Moore Capital Management LP boosted its position in shares of Synopsys by 41.3% during the second quarter. Moore Capital Management LP now owns 19,790 shares of the semiconductor company’s stock worth $8,828,000 after buying an additional 5,780 shares during the period. Institutional investors own 85.47% of the company’s stock.
Wall Street Analyst Weigh In
A number of brokerages recently issued reports on SNPS. Berenberg Bank set a $633.00 target price on Synopsys in a research report on Wednesday, May 27th. Citigroup raised their price target on shares of Synopsys from $600.00 to $610.00 and gave the stock a “buy” rating in a research note on Thursday, May 28th. Morgan Stanley lowered their price objective on shares of Synopsys from $525.00 to $500.00 and set an “equal weight” rating on the stock in a report on Wednesday, August 19th. Wells Fargo & Company cut their price objective on shares of Synopsys from $535.00 to $450.00 and set an “equal weight” rating on the stock in a research report on Tuesday, August 11th. Finally, Weiss Ratings raised shares of Synopsys from a “hold (c-)” rating to a “hold (c)” rating in a research report on Thursday, August 27th. Twelve research analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $561.28.
Synopsys Stock Down 5.6%
Synopsys stock opened at $414.82 on Wednesday. The company has a debt-to-equity ratio of 0.29, a current ratio of 1.34 and a quick ratio of 1.24. The company’s 50-day moving average is $415.20 and its 200-day moving average is $439.99. The firm has a market capitalization of $79.50 billion, a PE ratio of 73.29, a P/E/G ratio of 2.41 and a beta of 1.23. Synopsys, Inc. has a fifty-two week low of $366.00 and a fifty-two week high of $615.79.
Synopsys (NASDAQ:SNPS – Get Free Report) last issued its earnings results on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share (EPS) for the quarter, beating the consensus estimate of $3.67 by $0.24. Synopsys had a net margin of 11.43% and a return on equity of 6.24%. The business had revenue of $2.48 billion during the quarter, compared to the consensus estimate of $2.44 billion. During the same period last year, the business posted $3.39 EPS. Synopsys’s revenue was up 42.4% on a year-over-year basis. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. Sell-side analysts anticipate that Synopsys, Inc. will post 11 earnings per share for the current year.
Trending Headlines about Synopsys
Here are the key news stories impacting Synopsys this week:
- Positive Sentiment: Wall Street’s mean price target implies approximately 25.4% upside. Analysts’ improving earnings estimates provide a more meaningful bullish signal than the target-price average alone. Wall Street Analysts See a 25.39% Upside in Synopsys
- Positive Sentiment: Analyst sentiment remains broadly favorable, with a “Moderate Buy” consensus, 12 Buy ratings, and recent price targets as high as $580. Robert W. Baird also upgraded the stock to Outperform and raised its target to $560. Is It Worth Investing in Synopsys Based on Wall Street’s Bullish Views?
- Positive Sentiment: A bullish investor article highlights Synopsys’ 42.4% year-over-year quarterly revenue growth, recent earnings beat, and potential for the market to be underestimating its AI-related chip-design opportunity relative to peers. The Market May Be Underestimating This AI Chip-Design Stock
- Neutral Sentiment: A decade-long investment retrospective emphasizes Synopsys’ substantial long-term returns, but it is backward-looking and is unlikely to be a major near-term trading catalyst. Here’s How Much You’d Have If You Invested $1000 in Synopsys a Decade Ago
- Negative Sentiment: Executive Chair Aart de Geus sold 25,000 shares for approximately $11.1 million, reducing his holdings by 17.19%. The transaction was made under a pre-arranged Rule 10b5-1 plan, which lessens—but does not eliminate—the negative signaling effect. Synopsys Insider Geus Aart De Sells 25,000 Shares
- Negative Sentiment: Semiconductor stocks broadly came under pressure as a global bond selloff pushed long-term yields higher. Rising yields can weigh particularly heavily on high-multiple growth stocks such as Synopsys, which trades at an elevated valuation. Semiconductor Stocks Slide as Global Bond Selloff Lifts Yields
Insider Activity
In other news, insider Geus Aart De sold 25,000 shares of Synopsys stock in a transaction that occurred on Friday, August 28th. The stock was sold at an average price of $445.55, for a total transaction of $11,138,750.00. Following the completion of the transaction, the insider directly owned 120,421 shares in the company, valued at approximately $53,653,576.55. The trade was a 17.19% decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, CFO Shelagh Glaser sold 3,394 shares of the business’s stock in a transaction that occurred on Friday, June 12th. The stock was sold at an average price of $450.02, for a total value of $1,527,367.88. Following the transaction, the chief financial officer directly owned 14,358 shares in the company, valued at $6,461,387.16. The trade was a 19.12% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 42,997 shares of company stock valued at $19,368,311 over the last three months. Insiders own 0.56% of the company’s stock.
About Synopsys
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Featured Articles
- Five stocks we like better than Synopsys
- Dutch Bros Sell-Off Creates a Growth Opportunity
- NVIDIA’s MediaTek Bet Shows How It Plans to Defend Its AI Moat
- Is Abercrombie & Fitch’s Hot Streak Just Getting Started?
- Medtronic’s Stars Are Aligning for a Price Recovery
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).
Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.
